Company intelligence / Profile preview

Opocrin SpA

Corlo di Formigine, Modena, Italyopocrin.it ↗
Ownership
Private
Development stage
Commercial
01

Overview

Opocrin is a world leader in the production of heparin derivatives and active pharmaceutical ingredients. Their products include sodium heparin, calcium heparin, sulodexide, iron sucrose, and other pharmaceutical ingredients.

Therapeutic areas
CardiovascularHematology
Modalities
Biological and chemical active pharmaceutical ingredientsheparin derivatives
Industry
Biotech
02

Drug pipeline

1 asset

deligoparin

3
03

Partnerships

Partnerships with multinational pharmaceutical companies and local distributors in over 50 countries

Beyond the preview

Go deeper on Opocrin SpA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opocrin SpA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call